Ketorolac Tromethamine 30?mg ×?10 vials Wholesale price comparison
$2.00
Ketorolac Tromethamine (marketed as HaiXin®) is a potent NSAID for intravenous or intramuscular use, offering analgesic effects comparable to opioids without the risk of addiction or tolerance. This product is supplied as 30?mg in 1?mL sterile injection vials (10?×?1?mL) and is intended strictly for laboratory and preclinical research use. Not approved for therapeutic, clinical, diagnostic, or veterinary applications.
描述
Product Specifications
| Attribute | Details |
|---|---|
| Product Name | Ketorolac Tromethamine Injection (HaiXin®) |
| Generic Name | Ketorolac Tromethamine |
| CAS Number | 74103?06?3 zh.wikipedia.org+1yao.dxy.cn+1 |
| Molecular Formula | C??H??NO? |
| Molecular Weight | ~255.3?g/mol (ketorolac tromethamine salt) |
| Dosage Form | Sterile aqueous solution for IV/IM injection |
| Strength | 30?mg / 1?mL vial |
| Pack Size | 10 vials per box |
| Approval Number | China NMPA H20223467 |
| Product Code | 86981812000030 |
| Manufacturer | Nanjing Hairong Pharmaceutical Co., Ltd. |
| Barcode | 6973204570058 |
| Storage Conditions | Store at 2–25?°C; protect from light and moisture |
| Intended Use | Laboratory research only |
Mechanism of Action
Ketorolac is a non-selective cyclooxygenase (COX?1/COX?2) inhibitor that reduces prostaglandin and thromboxane synthesis. It delivers rapid analgesia and anti-inflammatory effects comparable to opioid strength .
Research Applications & Pharmacology
-
Acute Pain Models: Highly effective in preclinical studies of moderate to severe pain (e.g., post-operative, trauma, cancer pain).
-
Analgesia without Opioids: Recommended as a standalone or adjuvant to lessen opioid dosage and associated risks .
-
Administration Routes: Suitable for IV and IM injection; rapid onset (analgesia within 30 minutes; peak effect in 1–2?h; duration ~4–6?h) .
-
Pharmacokinetics: Bioavailability ~100% via injection, half?life 3.5–9?h depending on age, primarily excreted renally (~91%) .
Safety Profile & Handling
-
Adverse Effects: Common GI symptoms (nausea, abdominal pain), dizziness, injection-site discomfort; serious risks include GI bleeding, renal impairment, cardiovascular events, hypersensitivity .
-
Handling Precautions: Use sterile technique; inspect vials for particulates; avoid mixing with certain opioids/antiemetics to prevent precipitation .
-
Contraindications: Not suitable for active ulcers, bleeding disorders, renal/liver impairment, late-stage pregnancy, or combined use with other NSAIDs .
-
Storage: Seal at ?30?°C, shield from light; stable for 24 months ypsm.yzsbh.com.
其他信息
| 重量 | 1.1 公斤 |
|---|---|
| 尺寸 | 18 × 16 × 18 厘米 |
相关产品
-
Cisatracurium Besilate 10?mg / 5?mL Vial Wholesale price comparison
Cisatracurium besilate is an intermediate-acting, non-depolarizing neuromuscular blocking agent used in preclinical research for muscle relaxation, anesthesia modeling, and mechanical ventilation studies. It is one of the 10 stereoisomers of atracurium, offering greater potency and minimal histamine release. Each 5?mL vial contains 10?mg.
?? For laboratory research use only.?Please consult the staff for other purposes? $23.00 -
Bupivacaine Hydrochloride 37.5?mg ×?5 Vials Wholesale price comparison
Bupivacaine hydrochloride is a long-acting amide-type local anesthetic widely used in preclinical studies for nerve block, infiltration, epidural, and spinal anesthesia. Each box contains five 5?mL vials (37.5?mg per vial). Manufactured by Hunan Zhengqing Pharmaceutical Group Co., Ltd., approved under NMPA H43021018, product code 86904152004254.
?? For laboratory research use only.?Please consult the staff for other purposes? $2.00 -
Dexmedetomidine Hydrochloride Injection 0.2?mg/2?mL ×?5 Vials (Lyophilized Powder) [For Laboratory Research Use Only]
Dexmedetomidine hydrochloride is a highly selective ???adrenergic receptor agonist used in preclinical sedation and analgesia research. Each set includes five lyophilized vials of 0.2?mg dexmedetomidine in a 2?mL formulation. Produced by Sinopharm Group Langfang Co., Ltd., approved under NMPA H20203335 (product code: 86902581000113).
?? For laboratory research use only.?Please consult the staff for other purposes? $1.00 -
Diclofenac Sodium Enteric-Coated Tablets-Renhe Wholesale price comparison
Renhe® Diclofenac Sodium is an NSAID formulated in enteric-coated tablets to minimize gastric irritation. Each box contains three blister packs (24 tablets of 25?mg each, total 72 tablets). Manufactured by Baiyunshan Dongtai Shandong Pharmaceutical Co., Ltd., approved under NMPA H41022227, product code 86903081000221 (barcode?6922670003720).
?? For laboratory research use only.?Please consult the staff for other purposes? $3.00
评价
目前还没有评价